Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02053103
What this trial is testing

A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 13
Testing effectiveness (Phase 2)Study completedNCT02597127
What this trial is testing

Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Atherosclerotic Cardiovascular DiseaseFamilial HypercholesterolemiaDiabetes
The Medicines Company 501
Testing effectiveness (Phase 2)Study completedNCT02390050
What this trial is testing

A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Theracos 292
Early research (Phase 1)Study completedNCT01134224
What this trial is testing

A Trial Investigating the Effect of NN5401 in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 39
Large-scale testing (Phase 3)Study completedNCT00770653
What this trial is testing

Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.

Who this might be right for
Diabetes MellitusDyslipidemias
Takeda 305
Large-scale testing (Phase 3)Study completedNCT01128153
What this trial is testing

Saxagliptin Triple Oral Therapy

Who this might be right for
Type 2 Diabetes
AstraZeneca 257
Post-approval studies (Phase 4)Study completedNCT00095446
What this trial is testing

NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 513
Testing effectiveness (Phase 2)Study completedNCT01293669
What this trial is testing

Glycemic Control, Safety and Tolerability of TC-6987 Monotherapy in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Targacept Inc. 440
Post-approval studies (Phase 4)Study completedNCT00692237
What this trial is testing

Cardiovascular Effects of Chronic Sildenafil in Men With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Endothelial Dysfunction
University of Roma La Sapienza 59
Not applicableStudy completedNCT00614783
What this trial is testing

Screening for Early Evidence of Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
VeraLight, Inc. 3,478
Large-scale testing (Phase 3)Study completedNCT00135941
What this trial is testing

Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)

Who this might be right for
Diabetes Mellitus
Sanofi 582
Early research (Phase 1)Ended earlyNCT01202266
What this trial is testing

A Multiple Dose Study Of PF-05161704 In Healthy Volunteers

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 32
Large-scale testing (Phase 3)UnknownNCT01245166
What this trial is testing

A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
The Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mgPlus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks inSubjects With Type 2 Diabetes Mellitus.
Lotus Pharmaceutical
Large-scale testing (Phase 3)Study completedNCT00855166
What this trial is testing

Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 182
Not applicableStudy completedNCT03178019
What this trial is testing

DPP4 Activity, Microvascular Reactivity and Inflammation

Who this might be right for
OverweightPre DiabetesDiabetes Mellitus Type 2 Without Complication
Rio de Janeiro State University 52
Not applicableStudy completedNCT03829800
What this trial is testing

Formulas for Diabetes With Sucromalt & Isomaltulose on Glycemic Index, Hormones & Subjective Appetite in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Universidad del Zulia 23
Early research (Phase 1)Study completedNCT00774553
What this trial is testing

To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Metformin

Who this might be right for
Type 2 Diabetes
AstraZeneca 70
Not applicableStudy completedNCT04387045
What this trial is testing

Perceived Stress and Negative Thoughts With Biomarkers in People With Type 2 Diabetes Mellitus and Healthy Subjects

Who this might be right for
Diabetes Mellitus, Type 2
Francisco Carlos López Marquez 40
Testing effectiveness (Phase 2)Study completedNCT02470039
What this trial is testing

Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic Therapy

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 50
Early research (Phase 1)Study completedNCT00964964
What this trial is testing

A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 Diabetics

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 18
Next Page
220